IFN regulatory factor-2 regulates macrophage apoptosis through a STAT1/3- and caspase-1-dependent mechanism

Journal of Immunology

Volumn 178, Issue 6, 2007, Pages 3602-3611

  Cuesta, Natalia ^a   Nhu, Quan M ^a   Zudaire, Enrique ^b   Polumuri, Swamy ^a   Cuttitta, Frank ^b   Vogel, Stefanie N ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; GLIOTOXIN; INTERFERON REGULATORY FACTOR 2; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOSERINE; PHOSPHOTYROSINE; STAT1 PROTEIN; STAT3 ALPHA PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CASP1 GENE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA RESPONSIVE ELEMENT; DOWN REGULATION; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENE; GENE EXPRESSION PROFILING; LIVER; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN FUNCTION; STAT3 GENE;

EID: 33947278297     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.6.3602     Document Type: Article

References (73)

1. Akira, S., K. Takeda, and T. Kaisho. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2: 675-680.
2. Takeda, K., and S. Akira. 2005. Toll-like receptors in innate immunity. Int. Immunol. 17: 1-14.
3. Yokochi, T., A. Morikawa, Y. Kato, T. Sugiyama, and N. Koide. 1998. Apoptotic cell death in response to LPS. Prog. Clin. Biol. Res. 397: 235-242.
4. Wesche, D. E., J. L. Lomas-Neira, M. Perl, C. S. Chung, and A. Ayala. 2005. Leukocyte apoptosis and its significance in sepsis and shock. J. Leukocyte Biol. 78: 325-337.
5. Kim, S., E. Y. Chung, and X. Ma. 2005. Immunological consequences of macrophage-mediated clearance of apoptotic cells. Cell Cycle 4: 231-234.
6. Xaus, J., M. Comalada, A. F. Valledor, M. Cardo, C. Herrero, C. Soler, J. Lloberas, and A. Celada. 2001. Molecular mechanisms involved in macrophage survival, proliferation, activation or apoptosis. Immunobiology 204: 543-550.
7. Barber, G. N. 2001. Host defense, viruses and apoptosis. Cell Death Differ. 8: 113-126.
8. Chawla-Sarkar, M., D. J. Lindner, Y. F. Liu, B. R. Williams, G. C. Sen, R. H. Silverman, and E. C. Borden. 2003. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8: 237-249.
9. Bromberg, J., and J. E. Darnell, Jr. 2000. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19: 2468-2473.
10. Calo, V., M. Migliavacca, V. Bazan, M. Macaluso, M. Buscemi, N. Gebbia, and A. Russo. 2003. STAT proteins: from normal control of cellular events to tumorigenesis. J. Cell. Physiol. 197: 157-168.
11. Chapman, R. S., P. C. Lourenco, E. Tonner, D. J. Flint, S. Selbert, K. Takeda, S. Akira, A. R. Ctarke, and C. J. Watson. 1999. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev. 13: 2604-2616.
12. Ahmed-Choudhury, J., K. T. Williams, L. S. Young, D. H. Adams, and S. C. Afford. 2006. CD40 mediated human cholangiocyte apoptosis requires JAK2 dependent activation of STAT3 in addition to activation of JNK1/2 and ERK1/2. Cell Signal. 18: 456-468.
13. Chin, Y. E., M. Kitagawa, K. Kuida, R. A. Flavell, and X. Y. Fu. 1997. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol. Cell. Biol. 17: 5328-5337.
14. Haga, S., K. Terui, H. Q. Zhang, S. Enosawa, W. Ogawa, H. Inoue, T. Okuyama, K. Takeda, S. Akira, T. Ogino, et al. 2003. Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J. Clin. Invest. 112: 989-998.
15. Skov, S., M. Nielsen, S. Bregenholt, N. Odum, and M. H. Claesson. 1998. Activation of Stat-3 is involved in the induction of apoptosis after ligation of major histocompatibility complex class I molecules on human Jurkat T cells. Blood 91: 3566-3573.
16. Caldenhoven, E., T. B. van Dijk, R. Solari, J. Armstrong, J. A. Raaijmakers, J. W. Lammers, L. Koenderman, and R. P. de Groot. 1996. STAT3β, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J. Biol. Chem. 271: 13221-13227.
17. Hevehan, D. L., W. M. Miller, and E. T. Papoutsakis. 2002. Differential expression and phosphorylation of distinct STAT3 proteins during granulocytic differentiation. Blood 99: 1627-1637.
18. Maritano, D., M. L. Sugrue, S. Tininini, S. Dewilde, B. Strobl, X. Fu, V. Murray-Tait, R. Chiarle, and V. Poli. 2004. The STAT3 isoforms α and β have unique and specific functions. Nat. Immunol. 5: 401-409.
19. Darnell, J. E., Jr. 1997. STATs and gene regulation. Science 277: 1630-1635.
20. Garcia, R., T. L. Bowman, G. Niu, H. Yu, S. Minton, C. A. Muro-Cacho, C. E. Cox, R. Falcone, R. Fairclough, S. Parsons, et al. 2001. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 20: 2499-2513.
21. Wang, T., G. Niu, M. Kortylewski, L. Burdelya, K. Shain, S. Zhang, R. Bhattacharya, D. Gabrilovich, R. Heller, D. Coppola, et al. 2004. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat. Med. 10: 48-54.
22. Stephanou, A., and D. S. Latchman. 2003. STAT-1: a novel regulator of apoptosis. Int. J. Exp. Pathol. 84: 239-244.
23. Kim, H. S., and M. S. Lee. 2005. Essential role of STAT1 in caspase-independent cell death of activated macrophages through the p38 mitogen-activated protein kinase/STAT1/reactive oxygen species pathway. Mol. Cell. Biol. 25: 6821-6833.
24. Townsend, P. A., T. M. Scarabelli, S. M. Davidson, R. A. Knight, D. S. Latchman, and A. Stephanou. 2004. STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis. J. Biol. Chem. 279: 5811-5820.
25. Taniguchi, T., K. Ogasawara, A. Takaoka, and N. Tanaka. 2001. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19: 623-655.
26. Harada, H., T. Fujita, M. Miyamoto, Y. Kimura, M. Maruyama, A. Furia, T. Miyata, and T. Taniguchi. 1989. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58: 729-739.
27. Watanabe, N., J. Sakakibara, A. G. Hovanessian, T. Taniguchi, and T. Fujita. 1991. Activation of IFN-β element by IRF-1 requires a posttranslational event in addition to IRF-1 synthesis. Nucleic Acids Res. 19: 4421-4428.
28. Harada, H., E. Takahashi, S. Itoh, K. Harada, T. A. Hori, and T. Taniguchi. 1994. Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system. Mol. Cell. Biol. 14: 1500-1509.
29. Tanaka, N., M. Ishihara, M. S. Lamphier, H. Nozawa, T. Matsuyama, T. W. Mak, S. Aizawa, T. Tokino, M. Oren, and T. Taniguchi. 1996. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature 382: 816-818.
30. Tamura, T., M. Ishihara, M. S. Lamphier, N. Tanaka, I. Oishi, S. Aizawa, T. Matsuyama, T. W. Mak, S. Taki, and T. Taniguchi. 1995. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 376: 596-599.
31. Horiuchi, M., T. Yamada, W. Hayashida, and V. J. Dzau. 1997. Interferon regulatory factor-1 up-regulates angiotensin II type 2 receptor and induces apoptosis. J. Biol. Chem. 272: 11952-11958.
32. Horiuchi, M., H. Yamada, M. Akishita, M. Ito, K. Tamura, and V. J. Dzau. 1999. Interferon regulatory factors regulate interleukin-1β-converting enzyme expression and apoptosis in vascular smooth muscle cells. Hypertension 33: 162-166.
33. Kano, A., T. Haruyama, T. Akaike, and Y. Watanabe. 1999. IRF-1 is an essential mediator in IFN-γ-induced cell cycle arrest and apoptosis of primary cultured hepatocytes. Biochem. Biophys. Res. Commun. 257: 672-677.
34. Cuesta, N., C. A. Salkowski, K. E. Thomas, and S. N. Vogel. 2003. Regulation of lipopolysaccharide sensitivity by IFN regulatory factor-2. J. Immunol. 170: 5739-5747.
35. Taki, S., S. Nakajima, E. Ichikawa, T. Saito, and S. Hida. 2005. IFN regulatory factor-2 deficiency revealed a novel checkpoint critical for the generation of peripheral NK cells. J. Immunol. 174: 6005-6012.
36. Petrilli, V., S. Papin, and J. Tschopp. 2005. The inflammasome. Curr. Biol. 15: R581.
37. Martinon, F., and J. Tschopp. 2004. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117: 561-574.
38. L through caspase interaction. Proc. Natl. Acad. Sci. USA 95: 554-559.
39. Tamura, T., S. Ueda, M. Yoshida, M. Matsuzaki, H. Mohri, and T. Okubo. 1996. Interferon-γ induces Ice gene expression and enhances cellular susceptibility to apoptosis in the U937 leukemia cell line. Biochem. Biophys. Res. Commun. 229: 21-26.
40. Tamura, T., M. Ishihara, M. S. Lamphier, N. Tanaka, I. Oishi, S. Aizawa, T. Matsuyama, T. W. Mak, S. Taki, and T. Taniguchi. 1997. DNA damage-induced apoptosis and Ice gene induction in mitogenically activated T lymphocytes require IRF-1. Leukemia 11: 439-440.
41. Iwase, S., Y. Furukawa, J. Kikuchi, S. Saito, M. Nakamura, R. Nakayama, J. Horiguchi-Yamada, and H. Yamada. 1999. Defective binding of IRFs to the initiator element of interleukin-1β-converting enzyme (ICE) promoter in an interferon-resistant Daudi subline. FEBS Lett. 450: 263-267.
42. Matsuyama, T., T. Kimura, M. Kitagawa, K. Pfeffer, T. Kawakami, N. Watanabe, T. M. Kundig, R. Amakawa, K. Kishihara, A. Wakeham, et al. 1993. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75: 83-97.
43. McIntire, F. C., H. W. Sievert, G. H. Barlow, R. A. Finley, and A. Y. Lee. 1967. Chemical, physical, biological properties of a lipopolysaccharide from Escherichia coli K-235. Biochemistry 6: 2363-2372.
44. T method. Methods 25: 402-408.
45. Jegga, A. G., A. Gupta, S. Gowrisankar, M. A. Deshmukh, S. Connolly, K. Finley, and B. J. Aronow. 2005. CisMols analyzer: identification of compositionally similar cis-element clusters in ortholog conserved regions of coordinately expressed genes. Nucleic Acids Res. 33: W408-W411.
46. Hsu, S. M., L. Raine, and H. Fanger. 1981. Use of avidin-biotin- peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29: 577-580.
47. Nicoletti, I., G. Migliorati, M. C. Pagliacci, F. Grignani, and C. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139: 271-279.
48. Lakics, V., and S. N. Vogel. 1998. Lipopolysaccharide and ceramide use divergent signaling pathways to induce cell death in murine macrophages. J. Immunol. 161: 2490-2500.
49. Bassuk, A. G., and J. M. Leiden. 1997. The role of Ets transcription factors in the development and function of the mammalian immune system. Adv. Immunol. 64: 65-104.
50. Akira, S. 1999. Functional roles of STAT family proteins: lessons from knockout mice. Stem Cells 17: 138-146.
51. Hutton, J. J., A. G. Jegga, S. Kong, A. Gupta, C. Ebert, S. Williams, J. D. Katz, and B. J. Aronow. 2004. Microarray and comparative genomics-based identification of genes and gene regulatory regions of the mouse immune system. BMC Genomics 5: 82.
52. Bromberg, J. 2000. Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development. Breast Cancer Res. 2: 86-90.
53. Sommer, V. H., O. J. Clemmensen, O. Nielsen, M. Wasik, P. Lovato, C. Brender, K. W. Eriksen, A. Woetmann, C. G. Kaestel, M. H. Nissen, et al. 2004. In vivo activation of STAT3 in cutaneous T-cell lymphoma: evidence for an antiapoptotic function of STAT3. Leukemia 18: 1288-1295.
54. Stephanou, A., B. K. Brar, R. A. Knight, and D. S. Latchman. 2000. Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters. Cell Death Differ. 7: 329-330.
55. Stephanou, A., T. M. Scarabelli, B. K. Brar, Y. Nakanishi, M. Matsumura, R. A. Knight, and D. S. Latchman. 2001. Induction of apoptosis and Fas receptor/ Fas ligand expression by ischemia/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701. J. Biol. Chem. 276: 28340-28347.
56. Decker, T., and P. Kovarik. 2000. Serine phosphorylation of STATs. Oncogene 19: 2628-2637.
57. Turkson, J., J. S. Kim, S. Zhang, J. Yuan, M. Huang, M. Glenn, E. Haura, S. Sebti, A. D. Hamilton, and R. Jove. 2004. Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity. Mol. Cancer Ther. 3: 261-269.
58. Yoshino, A., Y. Katayama, T. Yokoyama, T. Watanabe, A. Ogino, T. Ota, C. Komine, T. Fukushima, and K. Kusama. 2005. Therapeutic implications of ihterferon regulatory factor (IRF)-1 and IRF-2 in diffusely infiltrating astrocytomas (DIA): response to Interferon (IFN)-β in glioblastoma cells and prognostic value for DIA. J. Neurooncol. 74: 249-260.
59. Kornblihtt, A. R., M. de la Mata, J. P. Fededa, M. J. Munoz, and G. Nogues. 2004. Multiple links between transcription and splicing. RNA 10: 1489-1498.
60. Miller, M., K. Huse, K. Szafranski, P. Rosenstiel, S. Schreiber, R. Backofen, and M. Platzer. 2006. Phylogenetically widespread alternative splicing at unusual GYNGYN donors. Genome Biol. 7: R65.1-R65.15.
61. Yoo, J. Y., D. L. Huso, D. Nathans, and S. Desiderio. 2002. Specific ablation of Stat3β distorts the pattern of Stat3-responsive gene expression and impairs recovery from endotoxic shock. Cell 108: 331-344.
62. Desiderio, S., and J. Y. Yoo. 2003. A genome-wide analysis of the acute-phase response and its regulation by Stat3β. Ann. NY Acad. Sci. 987: 280-284.
63. Sano, S., K. S. Chan, M. Kira, K. Kataoka, S. Takagi, M. Tarutani, S. Itami, K. Kiguchi, M. Yokoi, K. Sugasawa, et al. 2005. Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation. Cancer Res. 65: 5720-5729.
64. Zhang, X., P. Shan, J. Alam, X. Y. Fu, and P. J. Lee. 2005. Carbon monoxide differentially modulates STAT1 and STAT3 and inhibits apoptosis via a phosphatidylinositol 3-kinase/Akt and p38 kinase-dependent STAT3 pathway during anoxia-reoxygenation injury. J. Biol. Chem. 280: 8714-8721.
65. Bhattacharya, S., R. M. Ray, and L. R. Johnson. 2005. STAT3-mediated transcription of Bcl-2, Mcl-1 and C-IAP2 prevents apoptosis in polyamine-depleted cells. Biochem. J. 392: 335-344.
66. Shen, Y., G. Devgan, J. E. Darnell, Jr., and J. F. Bromberg. 2001. Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stal1. Proc. Natl. Acad. Sci. USA 98: 1543-1548.
67. Nakajima, K., Y. Yamanaka, K. Nakae, H. Kojima, M. Ichiba, N. Kiuchi, T. Kitaoka, T. Fukada, M. Hibi, and T. Hirano. 1996. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J. 15: 3651-3658.
68. O'Farrell, A. M., Y. Liu, K. W. Moore, and A. L. Mui. 1998. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways. EMBO J. 17: 1006-1018.
69. Gamero, A. M., R. Potla, J. Wegrzyn, M. Szelag, A. E. Edling, K. Shimoda, D. C. Link, J. Dulak, D. P. Baker, Y. Tanabe, et al. 2006. Activation of Tyk2 and Stat3 is required for the apoptotic actions of interferon-β in primary pro-B cells. J. Biol. Chem. 281: 16238-16244.
70. Stephanou, A., B. K. Brar, T. M. Scarabelli, A. K. Jonassen, D. M. Yellon, M. S. Marber, R. A. Knight, and D. S. Latchman. 2000. Ischemia-induced STAT-1 expression and activation play a critical role in cardiomyocyte apoptosis. J. Biol. Chem. 275: 10002-10008.
71. Lee, C. K., E. Smith, R. Gimeno, R. Gertner, and D. E. Levy. 2000. STAT1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-γ. J. Immunol. 164: 1286-1292.
72. Janjua, S., A. Stephanou, and D. S. Latchman. 2002. The C-terminal activation domain of the STAT-1 transcription factor is necessary and sufficient for stress-induced apoptosis. Cell Death Differ. 9: 1140-1146.
73. Wen, Z., Z. Zhong, and J. E. Darnell, Jr. 1995. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82: 241-250.